BridgeBio Oncology Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 17.88 M | $160.01 M | 0.00% | 57.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 4.89 M | $43.72 M | 0.00% | 15.69% |
| OMEGA FUND MANAGEMENT, LLC | 05/15/2026 | 3.29 M | $29.44 M | 0.00% | 10.56% |
| ECOR1 CAPITAL, LLC | 05/15/2026 | 2.82 M | $25.27 M | 0.00% | 9.06% |
| ALPHABET INC. | 05/08/2026 | 2.82 M | $25.27 M | 0.00% | 9.06% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 2.82 M | $25.22 M | -3.05% | 9.05% |
| ENAVATE SCIENCES GP, LLC | 05/15/2026 | 2.63 M | $23.51 M | 0.00% | 8.43% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.53 M | $22.63 M | -0.06% | 8.12% |
| NOVO HOLDINGS A/S | 05/15/2026 | 2.19 M | $19.56 M | 11.45% | 7.02% |
| BLACKROCK, INC. | 05/13/2026 | 2.09 M | $18.69 M | 0.17% | 6.71% |
| LAURION CAPITAL MANAGEMENT LP | 05/14/2026 | 1.92 M | $17.21 M | 31.24% | 6.17% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 1.33 M | $11.89 M | 32.80% | 4.26% |
| AISLING CAPITAL MANAGEMENT LP | 05/05/2026 | 1.02 M | $9.11 M | 80.30% | 3.27% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 868.21 K | $7.77 M | -61.61% | 2.79% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 719.00 K | $6.44 M | -31.07% | 2.31% |
| ROYCE & ASSOCIATES LP | 05/12/2026 | 636.52 K | $5.70 M | 100.00% | 2.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 579.23 K | $5.19 M | 3.07% | 1.86% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 541.18 K | $4.70 M | -50.00% | 1.74% |
| 05/15/2026 | 538.44 K | $4.82 M | 100.00% | 1.73% | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 437.89 K | $3.92 M | -45.48% | 1.41% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 400.00 K | $3.58 M | -71.43% | 1.28% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 320.87 K | $2.87 M | 100.00% | 1.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 290.81 K | $2.60 M | 4.21% | 0.93% |
| CASDIN CAPITAL, LLC | 05/15/2026 | 282.31 K | $2.53 M | 0.00% | 0.91% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 270.23 K | $2.42 M | 22.70% | 0.87% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 265.95 K | $2.38 M | 10.16% | 0.85% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 254.33 K | $2.28 M | 100.00% | 0.82% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/14/2026 | 249.16 K | $2.16 M | 100.00% | 0.80% |
| FMR LLC | 05/15/2026 | 240.30 K | $2.15 M | 0.00% | 0.77% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 231.04 K | $2.07 M | 100.00% | 0.74% |
| STATE STREET CORP | 05/15/2026 | 226.28 K | $2.03 M | 3.67% | 0.73% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 167.57 K | $1.50 M | 77.04% | 0.54% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 130.63 K | $1.17 M | 0.00% | 0.42% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 110.00 K | $984.50 K | 100.00% | 0.35% |
| WOODLINE PARTNERS LP | 05/15/2026 | 103.71 K | $928.18 K | 0.00% | 0.33% |
| NORTHERN TRUST CORP | 05/14/2026 | 102.26 K | $915.21 K | 76.20% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 101.90 K | $912.01 K | 37.15% | 0.33% |
| MOORE CAPITAL MANAGEMENT, LP | 05/15/2026 | 100.00 K | $895.00 K | 0.00% | 0.32% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 90.82 K | $812.83 K | 243.08% | 0.29% |
| TOROSO INVESTMENTS, LLC | 05/15/2026 | 82.17 K | $735.44 K | 100.00% | 0.26% |
| TEMA ETFS LLC | 04/15/2026 | 82.17 K | $735.44 K | 100.00% | 0.26% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 80.88 K | $723.91 K | 20.66% | 0.26% |
| HIGHVISTA STRATEGIES LLC | 05/15/2026 | 78.19 K | $699.77 K | -65.90% | 0.25% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 71.93 K | $643.73 K | 100.06% | 0.23% |
| XTX TOPCO LTD | 05/15/2026 | 59.74 K | $534.70 K | 108.65% | 0.19% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 57.57 K | $515.27 K | -50.86% | 0.18% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 53.28 K | $476.87 K | 100.00% | 0.17% |
| UBS GROUP AG | 05/05/2026 | 50.45 K | $451.53 K | -45.97% | 0.16% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 48.12 K | $430.69 K | 100.00% | 0.15% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/28/2026 | 43.85 K | $392.48 K | 100.00% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BridgeBio Oncology Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 75 institutional investors and hedge funds held shares of BridgeBio Oncology Therapeutics Inc.. The most heavily invested institutionals were:
Cormorant Asset Management, LP: 17.88 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 4.89 M
Omega Fund Management, LLC: 3.29 M
EcoR1 Capital, LLC: 2.82 M
Alphabet Inc.: 2.82 M
WELLINGTON MANAGEMENT GROUP LLP: 2.82 M
184.41% of BridgeBio Oncology Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 57.69 M shares in the last 24 months. This purchase volume represents approximately $594.81 M in transactions.